Assignee
INTERCEPT PHARMACEUTICALS INC
US51 patents
Top patents by PatentIndex Score
US9763964B2Sep 19, 2017
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC23 citations93
US8377916B2Feb 19, 2013
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC15 citations93
US7812011B2Oct 12, 2010
Steroid agonist for FXR
INTERCEPT PHARMACEUTICALS INC18 citations93
US7786102B2Aug 31, 2010
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC20 citations93
US7994352B2Aug 9, 2011
Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acid
INTERCEPT PHARMACEUTICALS INC22 citations92
US7932244B2Apr 26, 2011
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC24 citations92
US7858608B2Dec 28, 2010
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC21 citations92
US10052337B2Aug 21, 2018
Compositions of obeticholic acid and methods of use
INTERCEPT PHARMACEUTICALS INC21 citations90
US9732116B2Aug 15, 2017
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC20 citations90
US9238673B2Jan 19, 2016
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC12 citations90
US10532061B2Jan 14, 2020
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC5 citations84
US9732117B2Aug 15, 2017
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC3 citations84
US9650409B2May 16, 2017
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC4 citations84
US9611289B2Apr 4, 2017
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC13 citations84
US10421772B2Sep 24, 2019
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC1 citations73
US9540414B2Jan 10, 2017
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC4 citations73
US9243027B2Jan 26, 2016
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC5 citations73
US11034717B2Jun 15, 2021
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC3 citations72
US9777038B2Oct 3, 2017
Process for preparing bile acid derivatives
INTERCEPT PHARMACEUTICALS INC3 citations72
US10047117B2Aug 14, 2018
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC2 citations70
US10894054B2Jan 19, 2021
FXR agonist compositions for combination therapy
INTERCEPT PHARMACEUTICALS INC3 citations69
US10758549B2Sep 1, 2020
Compositions of obeticholic acid and methods of use
INTERCEPT PHARMACEUTICALS INC2 citations69
US10646499B2May 12, 2020
Compositions of obeticholic acid and methods of use
INTERCEPT PHARMACEUTICALS INC1 citations69
US11345721B2May 31, 2022
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC2 citations68
US10800807B2Oct 13, 2020
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC3 citations68
US11066437B2Jul 20, 2021
Methods and intermediates for the preparation of bile acid derivatives
INTERCEPT PHARMACEUTICALS INC2 citations65
US11000532B2May 11, 2021
Farnesoid x receptor modulators
INTERCEPT PHARMACEUTICALS INC0 citations63
US8969330B2Mar 3, 2015
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC2 citations63
US10987362B2Apr 27, 2021
Treatment of fibrosis using FXR ligands
INTERCEPT PHARMACEUTICALS INC0 citations62
US9090652B2Jul 28, 2015
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
INTERCEPT PHARMACEUTICALS INC3 citations62
US12291549B2May 6, 2025
Farnesoid X receptor modulators
INTERCEPT PHARMACEUTICALS INC0 citations61
US11319337B2May 3, 2022
3-desoxy derivative and pharmaceutical compositions thereof
INTERCEPT PHARMACEUTICALS INC0 citations61
US10815267B2Oct 27, 2020
3-desoxy derivative and pharmaceutical compositions thereof
INTERCEPT PHARMACEUTICALS INC1 citations61
US10155787B2Dec 18, 2018
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC1 citations60
US12337003B2Jun 24, 2025
Pharmaceutical compositions for combination therapy
INTERCEPT PHARMACEUTICALS INC0 citations59
US11311557B2Apr 26, 2022
Pharmaceutical compositions for combination therapy
INTERCEPT PHARMACEUTICALS INC1 citations59
US11807659B2Nov 7, 2023
TGR5 modulators and methods of use thereof
INTERCEPT PHARMACEUTICALS INC0 citations58
US11413295B2Aug 16, 2022
Oral preparation of obeticholic acid
INTERCEPT PHARMACEUTICALS INC0 citations52
US11331273B2May 17, 2022
Film-coated tablet having high chemical stability of active ingredient
INTERCEPT PHARMACEUTICALS INC0 citations52
USRE48286EOct 27, 2020
Steroids as agonists for FXR
INTERCEPT PHARMACEUTICALS INC0 citations52
US10174073B2Jan 8, 2019
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC0 citations49
US9982008B2May 29, 2018
Preparation and uses of obeticholic acid
INTERCEPT PHARMACEUTICALS INC0 citations49
US10751349B2Aug 25, 2020
Compositions of obeticholic acid and methods of use
INTERCEPT PHARMACEUTICALS INC0 citations48
US10550146B2Feb 4, 2020
Methods for the preparation of obeticholic acid and derivatives thereof
INTERCEPT PHARMACEUTICALS INC0 citations44
US11419878B2Aug 23, 2022
Medicine obtained by combining FXR agonist and ARB
INTERCEPT PHARMACEUTICALS INC0 citations43
US11472831B2Oct 18, 2022
Isotopically labeled bile acid derivatives
INTERCEPT PHARMACEUTICALS INC0 citations40
US10414791B2Sep 17, 2019
Methods for preparation of bile acids and derivatives thereof
INTERCEPT PHARMACEUTICALS INC0 citations40
US10604544B2Mar 31, 2020
Methods for preparation of bile acids and derivatives thereof
INTERCEPT PHARMACEUTICALS INC0 citations35
US10369160B2Aug 6, 2019
Methods of treating cancer
INTERCEPT PHARMACEUTICALS INC0 citations33
US11072631B2Jul 27, 2021
Methods and intermediates for the preparation bile acid derivatives
INTERCEPT PHARMACEUTICALS INC0 citations32
Showing the top 50 of 51 patents by PatentIndex Score.